questionsmedicales.fr
Régions géographiques
Asie
Extrême-Orient
Extrême-Orient : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Extrême-Orient : Questions médicales les plus fréquentes",
"headline": "Extrême-Orient : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Extrême-Orient : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Extrême-Orient"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Asie",
"url": "https://questionsmedicales.fr/mesh/D001208",
"about": {
"@type": "MedicalCondition",
"name": "Asie",
"code": {
"@type": "MedicalCode",
"code": "D001208",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chine",
"alternateName": "China",
"url": "https://questionsmedicales.fr/mesh/D002681",
"about": {
"@type": "MedicalCondition",
"name": "Chine",
"code": {
"@type": "MedicalCode",
"code": "D002681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.164"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hong Kong",
"alternateName": "Hong Kong",
"url": "https://questionsmedicales.fr/mesh/D006723",
"about": {
"@type": "MedicalCondition",
"name": "Hong Kong",
"code": {
"@type": "MedicalCode",
"code": "D006723",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.164.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tibet",
"alternateName": "Tibet",
"url": "https://questionsmedicales.fr/mesh/D018609",
"about": {
"@type": "MedicalCondition",
"name": "Tibet",
"code": {
"@type": "MedicalCode",
"code": "D018609",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.164.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "République démocratique populaire de Corée",
"alternateName": "Democratic People's Republic of Korea",
"url": "https://questionsmedicales.fr/mesh/D056911",
"about": {
"@type": "MedicalCondition",
"name": "République démocratique populaire de Corée",
"code": {
"@type": "MedicalCode",
"code": "D056911",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.557.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "République de Corée",
"alternateName": "Republic of Korea",
"url": "https://questionsmedicales.fr/mesh/D056910",
"about": {
"@type": "MedicalCondition",
"name": "République de Corée",
"code": {
"@type": "MedicalCode",
"code": "D056910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.557.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mongolie",
"alternateName": "Mongolia",
"url": "https://questionsmedicales.fr/mesh/D008986",
"about": {
"@type": "MedicalCondition",
"name": "Mongolie",
"code": {
"@type": "MedicalCode",
"code": "D008986",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.252.474.651"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Extrême-Orient",
"alternateName": "Asia, Eastern",
"code": {
"@type": "MedicalCode",
"code": "D005202",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Masoud Dara",
"url": "https://questionsmedicales.fr/author/Masoud%20Dara",
"affiliation": {
"@type": "Organization",
"name": "WHO Regional Office for Europe, Copenhagen, Denmark. Electronic address: daram@who.int."
}
},
{
"@type": "Person",
"name": "Yakubu Egigogo Raji",
"url": "https://questionsmedicales.fr/author/Yakubu%20Egigogo%20Raji",
"affiliation": {
"@type": "Organization",
"name": "Department of Medical Microbiology Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": "European Board and College of Obstetrics and Gynaecology (EBCOG), European Society of Contraception and Reproductive Health (ESCRH)."
}
},
{
"@type": "Person",
"name": "Tzung-Dau Wang",
"url": "https://questionsmedicales.fr/author/Tzung-Dau%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan."
}
},
{
"@type": "Person",
"name": "Kazuomi Kario",
"url": "https://questionsmedicales.fr/author/Kazuomi%20Kario",
"affiliation": {
"@type": "Organization",
"name": "Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Asie",
"item": "https://questionsmedicales.fr/mesh/D001208"
},
{
"@type": "ListItem",
"position": 4,
"name": "Extrême-Orient",
"item": "https://questionsmedicales.fr/mesh/D005202"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Extrême-Orient - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Extrême-Orient",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Extrême-Orient",
"description": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?\nQuels examens pour le cancer du foie en Asie ?\nComment identifier une tuberculose en Extrême-Orient ?\nQuels tests pour le paludisme en Asie ?\nComment diagnostiquer une hépatite virale ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Extrême-Orient",
"description": "Quels sont les symptômes du choléra ?\nQuels signes d'une infection par le virus Nipah ?\nQuels symptômes de la dengue ?\nQuels symptômes de la grippe aviaire ?\nQuels signes d'une infection à Hantavirus ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Extrême-Orient",
"description": "Comment prévenir le choléra ?\nQuelles mesures pour éviter la dengue ?\nComment prévenir la tuberculose ?\nQuelles précautions pour le paludisme ?\nComment éviter l'hépatite A ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Extrême-Orient",
"description": "Quel traitement pour la tuberculose ?\nComment traiter le paludisme ?\nQuel traitement pour l'hépatite B ?\nComment traiter la dengue ?\nQuel traitement pour le choléra ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Extrême-Orient",
"description": "Quelles complications du choléra ?\nQuelles complications de la dengue ?\nQuelles complications de l'hépatite B ?\nQuelles complications de la tuberculose ?\nQuelles complications du paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Extrême-Orient",
"description": "Quels sont les facteurs de risque du choléra ?\nQuels facteurs de risque pour la dengue ?\nQuels facteurs de risque pour l'hépatite A ?\nQuels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le paludisme ?",
"url": "https://questionsmedicales.fr/mesh/D005202?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection parasitaire en Extrême-Orient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur des tests sanguins, des analyses de selles et des antécédents de voyage."
}
},
{
"@type": "Question",
"name": "Quels examens pour le cancer du foie en Asie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie, la tomodensitométrie et les tests de marqueurs tumoraux sont utilisés."
}
},
{
"@type": "Question",
"name": "Comment identifier une tuberculose en Extrême-Orient ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test cutané, une radiographie pulmonaire et des cultures de crachats sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels tests pour le paludisme en Asie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins spécifiques, comme le frottis sanguin, sont utilisés pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Comment diagnostiquer une hépatite virale ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins pour détecter les anticorps et les antigènes sont effectués."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du choléra ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent diarrhée aqueuse, vomissements et déshydratation rapide."
}
},
{
"@type": "Question",
"name": "Quels signes d'une infection par le virus Nipah ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, maux de tête, confusion et troubles respiratoires sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la dengue ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et saignements peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes de la grippe aviaire ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, toux, difficultés respiratoires et douleurs musculaires sont typiques."
}
},
{
"@type": "Question",
"name": "Quels signes d'une infection à Hantavirus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs abdominales, et symptômes respiratoires peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment prévenir le choléra ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'accès à l'eau potable, l'hygiène et la vaccination sont cruciaux."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la dengue ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éliminer les eaux stagnantes et utiliser des répulsifs contre les moustiques sont efficaces."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG et le dépistage précoce des cas sont recommandés."
}
},
{
"@type": "Question",
"name": "Quelles précautions pour le paludisme ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des moustiquaires et des médicaments prophylactiques lors de voyages à risque."
}
},
{
"@type": "Question",
"name": "Comment éviter l'hépatite A ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, consommer de l'eau potable et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement standard inclut des antibiotiques sur plusieurs mois, comme l'isoniazide."
}
},
{
"@type": "Question",
"name": "Comment traiter le paludisme ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments antipaludiques comme la chloroquine ou l'artémisinine sont prescrits."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'hépatite B ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux comme le ténofovir et l'entécavir sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Comment traiter la dengue ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement spécifique ; la réhydratation et le soulagement des symptômes sont essentiels."
}
},
{
"@type": "Question",
"name": "Quel traitement pour le choléra ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réhydratation orale ou intraveineuse et les antibiotiques sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles complications du choléra ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation sévère et le choc hypovolémique peuvent être mortels."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dengue ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le syndrome de choc dengue et les hémorragies peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite B ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cirrhose et le cancer du foie sont des complications possibles à long terme."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la fibrose pulmonaire et la dissémination à d'autres organes."
}
},
{
"@type": "Question",
"name": "Quelles complications du paludisme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anémie sévère, l'insuffisance rénale et le coma peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du choléra ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'accès limité à l'eau potable et une mauvaise hygiène augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dengue ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre dans des zones tropicales et avoir des moustiques à proximité sont des risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'hépatite A ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Voyager dans des régions à risque et consommer des aliments contaminés augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "La malnutrition, le VIH et le surpeuplement sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le paludisme ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vivre ou voyager dans des zones endémiques et ne pas utiliser de protection contre les moustiques."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...